Valorising magnetometry in cells

This project aims to commercialize diamond magnetometry for measuring free radical generation in living cells, potentially leading to a startup focused on innovative diagnostic solutions.

Subsidie
€ 150.000
2022

Projectdetails

Introduction

Magnetic resonance spectroscopy (NMR or ESR) and magnetic resonance imaging (MRI) are widely used. However, magnetic resonance signals are low in energy and thus difficult to detect. These techniques are expensive and typically only offer millimeter down to micrometer resolution.

Diamond Magnetometry

Diamond magnetometry potentially offers a solution. The technique is based on a quantum effect and allows even the detection of single electron spins. While the technique has been used for a few years in physics, during my ERC project, this powerful tool was utilized for the first time to measure metabolic activity in living cells.

Project Aim

The aim of this project is to explore the commercial potential of these results and, if it is deemed feasible, found a start-up company for exploitation.

Application Focus

As a first application, we will investigate free radical generation. These molecules play a key role in many biological processes, including:

  1. Cell communication
  2. Immune responses
  3. Ageing

Additionally, they are an indicator of stress and thus play a role in many diseases, including cancer, cardiovascular diseases, or viral and bacterial infections.

Challenges with Free Radicals

Despite their relevance and the fact that free radical generation is often an early sign of disease, they are rarely used as biomarkers since they are notoriously difficult to measure.

Prototype Development

In this project, we will build a prototype (to be patented) that can be used for demonstrations to customers. This will be done in close collaboration with a user committee in order to meet customer expectations.

Demonstration and Business Model

To demonstrate the usefulness to customers for diagnosis, we will conduct test measurements. Further, we will assess whether a business model based on a product, based on services, or a hybrid business model containing both is most promising.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-10-2022
Einddatum31-3-2024
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • ACADEMISCH ZIEKENHUIS GRONINGENpenvoerder

Land(en)

Netherlands

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000

Vergelijkbare projecten uit andere regelingen

ERC STG

Hyperpolarized Magnetic Resonance at the point-of-care

HYPMET aims to revolutionize personalized cancer treatment by developing a compact NMR technology for real-time monitoring of metabolic pathways and body fluid analyses using enhanced hyperpolarization methods.

€ 1.499.968
EIC Transition

Magnetic Resonance at the Scale of a Cell

The HyperCell project aims to revolutionize cell research by developing a non-invasive benchtop tool for single-cell metabolic analysis, enhancing understanding of diseases and treatment responses.

€ 1.998.750